MedCap Corp Begins Acquiring Rights to Additional Rapid Test Kits
TORONTO -- MedCap Corp is pleased to announce that it has begun negotiations to increase the line of AccuScan rapid test kits by adding rapid test kits for the detection of sexually transmitted diseases (STDs). The company feels that adding the test kits for STDs will complement the demand for the kits related to the drugs of abuse.
The combination of rapid test kits for drugs of abuse and STDs will give the company a comprehensive line of test kits. The demand for rapid test kits for STDs and drugs of abuse that are accurate, fast, inexpensive and can be used in the privacy of your own home is virtually unlimited. In the United States alone there are 15 million new cases of STDs each year. At least one in four Americans will contract an STD at some point in their lives. Two thirds of all STDs occur in people 25 years of age or younger. One in four new STD infections occur in teenagers. Less than half of the adults ages 18 to 44 have ever been tested for an STD other than HIV/AIDS .
Market studies show that the combination of test kits for drugs of abuse and STDs is a good product line for our distribution network. As the distribution network gets established, it is reasonable to expect that the company will sell in excess of 3,000,000 test kits per year.
Source: MedCap Corp.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
